Figure 3. Silencing of SLD5 attenuates tumor growth.
Bladder cancer cells (T24) were subcutaneously transplanted into nude mice. Control or SLD5-specific siRNA was injected on day10 post-inoculation. (A) Time course of tumor volume dynamics. Data are mean ± SE (n = 3). (B) Tumor weight on day 30 post-inoculation. *p < 0.05 mean ± SE. (C) qRT-PCR analysis for assessment of SLD5 mRNA expression in control and SLD5 siRNA-injected tumors. Data are mean ± SE ***p < 0.0001. (D) Xenograft tumors injected with control or SLD5 siRNA were stained with anti-SLD5 or Ki-67 antibody (brown). Sections were counterstained with hematoxylin. Scale bars: 100 μm.